Progesterone (P4) is the only hormone needed to maintain pregnancy in dogs. Therefore, a competitive inhibitor of 3β-hydroxysteroid dehydrogenase (3β-HSD) could be a safe and effective option to terminate pregnancy by inhibiting P4 synthesis. To address this hypothesis, we investigated the efficacy of trilostane (TRL), a competitive inhibitor of 3β-HSD, in terminating pregnancy in dogs. Twenty-one dogs between days 30 and 38 of pregnancy were randomly assigned to one of two treatment groups (trilostane (TRL) and aglepristone (AGL)) and an untreated control (CON) group (n = 7 dogs each). Fetal heart rates (FHRs) (measured at 12 h intervals) and serum P4 concentrations (measured at 6 h intervals) were evaluated. The pregnancy termination rates were 0% and 100% in the TRL and AGL groups, respectively. The decrease in the FHR in the TRL and AGL groups was significantly lower than that observed in the CON group. There was a marked decrease in P4 concentrations in the TRL group 6, 54, and 102 h after the initiation of treatment. The luteal expression of StAR appeared to be weaker in the AGL group than the CON group. In conclusion, although a treatment-induced decrease was observed in plasma P4 concentrations, a seven-day TRL treatment alone was not effective in terminating pregnancies. Further studies are needed on the effects of the prolonged administration of TRL with varying doses and frequencies for the termination of mid-term pregnancy in dogs.
27 September 2021 in Ankara Üniversitesi Veteriner Fakültesi Dergisi
Here we present a case of complete uterine prolapse in a cat following a third parturition at the age of 18 months. Upon examination, complete uterine prolapse was diagnosed because the mass protruding from the vulva had both uterine corn. After the invagination and eversion were corrected, and the uterus brought to its anatomical position, an ovariohysterectomy was performed. Urine output at the 1st postoperative hour and eating and drinking at the 24th hour were observed. Sutures were removed 10 days after the operation and treatment ended. Ovariohysterectomy after easily repositioning the uterus by keeping it in hypertonic fluid before surgery is a suitable and reliable option for cats suffering complete uterine prolapse. Özet: Bu olguda, üçüncü doğumunu takiben tam uterus prolapsusu şekillenen 18 aylık bir kedi sunulmaktadır. Muayenede, her iki kornu uterinin vulvadan dışarı çıkması sebebiyle tam uterus prolapsusu tanısı konuldu. İnvaginasyon ve eversiyon düzeltilip uterus anatomik pozisyonuna getirildikten sonra ovaryohisterektomi yapıldı. Hastada postoperatif 1. saatte idrar çıkışı ve 24. saatte yeme ve içme olduğu görüldü. Operasyondan 10 gün sonra dikişler alınarak tedaviye son verildi. Operasyon öncesi uterusun hipertonik sıvıda tutularak kolayca yeniden konumlandırılmasından sonra ovaryohisterektomi yapılması, tam uterus prolapsusu olan kediler için uygun ve güvenilir bir seçenektir.
31 December 2024 in Dicle Üniversitesi Veteriner Fakültesi Dergisi
Serum amyloid A (SAA) level increases in conditions such as infection, tissue damage and trauma and is not specific to a disease but provides information about the presence and severity of inflammation. As a life-threating conditions pyometra usually causes systemic inflammatory response syndrome (SIRS) and therefore may lead an increase in SAA levels. The present study was designed to determine SAA levels in cats with pyometra that developed SIRS, and to demonstrate the diagnostic value of SAA by comparing it with hematological and biochemical parameters as well as SIRS criteria. For this purpose, data were used from cats with open-cervix pyometra (OP, n=6) and closed-cervix pyometra (CP, n=6), which were identified as having developed SIRS and were admitted to hospital as well as from healthy cats brought in for routine neutering, which were identified to be in the diestrus phase of the sexual cycle (DE, n=6). Cats with pyometra had higher SAA levels and leukocytosis compared to cats in the DE group (P= 0.002 and P= 0.000, respectively). The highest SAA level was detected in the CP group (168.6 µg/ml) and this level is statistically significant compared to the other groups (P= 0.028). While there was no correlation between SAA levels and SIRS criteria, SAA levels were negatively correlated with both AST (P= 0.045, rs=-0.478) and GGT (P= 0.019, rs= -0.548). In the study, it was determined that sepsis and SIRS progressed with different symptoms in cats and SIRS criteria were less specific in cats. It was concluded that SAA levels may be an important marker in closed-cervix pyometra cases. We think that the study data are promising but further and comprehensive studies are needed considering the number of patients included in the study.
1 July 2026 in Ankara Üniversitesi Veteriner Fakültesi Dergisi
Mastitis frequently originates during the dry period, and abrupt drying-off in high-yielding dairy cows increases milk leakage, delays udder involution, and predisposes them to intramammary infections. Prolactin inhibitors, such as cabergoline (CAB), may help mitigate these challenges. Sixty-five Holstein-Friesian cows were assigned to the cabergoline group (GCAB, n=33) or control group (GCON, n=32). At drying-off, GCAB cows received a single intramuscular dose of 5.6 mg of CAB, while GCON cows received 5 mL of 0.9% NaCl. Milk leakage, teat measurements, and postpartum mastitis incidence were monitored. Milk leakage was significantly lower in GCAB group (Day 1: 3% vs. 46.9%; Day 2: 18.2% vs. 56.3%). Teat measurements indicated faster udder involution in GCAB (Day 1: 6.90 ± 2.01 cm vs. 8.29 ± 1.56 cm; Day 2: 7.37 ± 1.79 cm vs. 8.84 ± 1.86 cm). The incidence of postpartum mastitis was lower in the GCAB group (3.0% vs. 21.9%). CAB was well tolerated, and no major adverse effects were observed. The study was limited to a single farm and a relatively small sample size, which may restrict generalizability. Larger, multicenter studies are needed to confirm these findings. Single-dose CAB administered at abrupt drying-off effectively reduces milk leakage, accelerates udder involution, and decreases the risk of postpartum mastitis. CAB may be a promising non-antibiotic strategy to improve dry period management in dairy cows.
Pyometra is a frequent and life-threatening reproductive disorder in bitches, characterized by profound immune and inflammatory responses within the uterus. The endocannabinoid system (eCS) is a key modulator of immune regulation, tissue homeostasis, and inflammation; however, its role in canine uterine physiology and pathology remains unexplored. This study aimed to characterize the presence and regulation of eCS components in the uterus of healthy and pyometra-affected dogs. Twenty-eight bitches were categorized into four groups: closed-cervix pyometra (CP; n = 7), open-cervix pyometra (OP; n = 7), diestrus (DE; n = 7), and anestrus (AE; n = 7). Uterine tissues were obtained by ovariohysterectomy. Serum progesterone, anandamide (AEA), and 2-arachidonylglycerol (2-AG) concentrations were quantified, while the uterine expression of cannabinoid receptors (CB1 and CB2) was assessed using real-time PCR and localized by immunohistochemistry (IHC). Serum AEA levels were significantly reduced in CP compared with AE (p = 0.017), whereas 2-AG differences did not reach significance (p = 0.072). Both CB1 and CB2 were consistently expressed across all groups, with IHC revealing receptor-specific patterns within uterine compartments. Collectively, these findings demonstrate for the first time that the canine uterus possesses a functional eCS, and that its modulation is linked to reproductive physiology and pyometra-associated inflammatory processes.
31 October 2026 in Ankara Üniversitesi Veteriner Fakültesi Dergisi
Mid-term pregnancy termination in queens remains clinically challenging due to endocrine adaptations that reduce the efficacy of conventional abortifacient protocols. This study evaluated whether administration of prostaglandin (PG) following pretreatment with aglepristone (AGL) accelerated the onset and completion of abortion in mid-term pregnant queens. Thirty-five queens at 30–38 days of gestation were randomly allocated to five groups: AGL alone, AGL followed by oral misoprostol (MIS; 200 μg/queen) at 24 or 36 h, and AGL followed by subcutaneous cloprostenol (CLO; 5 μg/kg) at 24 or 36 h after the first AGL administration. Abortion outcomes included the time to abortion onset (TAO), time to abortion completion (TAC), abortion duration (AD), abortion induction rate (AIR) and abortion completion rate (ACR). Kaplan–Meier analysis results revealed significant differences between the treatment groups for both time to abortion onset and time to abortion completion (both P<0.001), whereas AIR and ACR did not differ statistically between the groups. No treatment-related adverse effects were observed. Serum progesterone concentrations changed significantly over time, whereas neither the treatment group effect nor the treatment group-by-time interaction was statistically significant. These findings suggest that AGL pretreatment may enhance uterine responsiveness to PG during mid-term pregnancy in queens, facilitating more rapid abortion without compromising safety. From a clinical perspective, CLO administration 24 h after AGL pretreatment appears to be a practical and time-efficient protocol for terminating of mid-term pregnancy in queens.
About Me
Obstetric and gynecology
Reproduction
Doppler USG
Dry period
Mastitis
Obstetric and gynecology
Reproduction
Doppler USG
Dry period
Mastitis